NO307421B1 - Nye 1,1-bis(heteroazolyl)alkanderivater, farmasøytisk preparat inneholdende slike derivater, deres anvendelse, samt mellomprodukter - Google Patents
Nye 1,1-bis(heteroazolyl)alkanderivater, farmasøytisk preparat inneholdende slike derivater, deres anvendelse, samt mellomprodukterInfo
- Publication number
- NO307421B1 NO307421B1 NO965182A NO965182A NO307421B1 NO 307421 B1 NO307421 B1 NO 307421B1 NO 965182 A NO965182 A NO 965182A NO 965182 A NO965182 A NO 965182A NO 307421 B1 NO307421 B1 NO 307421B1
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- heteroazolyl
- intermediates
- bis
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9401965A SE9401965D0 (sv) | 1994-06-07 | 1994-06-07 | New compounds |
PCT/SE1995/000604 WO1995033747A1 (en) | 1994-06-07 | 1995-05-29 | Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents |
Publications (3)
Publication Number | Publication Date |
---|---|
NO965182L NO965182L (no) | 1996-12-04 |
NO965182D0 NO965182D0 (no) | 1996-12-04 |
NO307421B1 true NO307421B1 (no) | 2000-04-03 |
Family
ID=20394274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO965182A NO307421B1 (no) | 1994-06-07 | 1996-12-04 | Nye 1,1-bis(heteroazolyl)alkanderivater, farmasøytisk preparat inneholdende slike derivater, deres anvendelse, samt mellomprodukter |
Country Status (26)
Country | Link |
---|---|
US (2) | US5843971A (is) |
EP (1) | EP0765325A1 (is) |
JP (1) | JPH10503172A (is) |
CN (1) | CN1051546C (is) |
AU (1) | AU691303B2 (is) |
BR (1) | BR9507923A (is) |
CA (1) | CA2190128A1 (is) |
CZ (1) | CZ357796A3 (is) |
DZ (1) | DZ1895A1 (is) |
EE (1) | EE9600197A (is) |
FI (1) | FI964879A (is) |
HR (1) | HRP950302A2 (is) |
HU (1) | HUT76050A (is) |
IL (1) | IL113773A (is) |
IS (1) | IS4383A (is) |
MA (1) | MA23574A1 (is) |
NO (1) | NO307421B1 (is) |
NZ (1) | NZ287973A (is) |
PL (1) | PL318470A1 (is) |
RU (1) | RU2155763C2 (is) |
SE (1) | SE9401965D0 (is) |
SK (1) | SK155696A3 (is) |
TN (1) | TNSN95065A1 (is) |
WO (1) | WO1995033747A1 (is) |
YU (1) | YU38695A (is) |
ZA (1) | ZA954145B (is) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9401965D0 (sv) * | 1994-06-07 | 1994-06-07 | Astra Ab | New compounds |
US6921538B2 (en) * | 2002-05-10 | 2005-07-26 | Allergan, Inc. | Therapeutic treatments for neuropsychiatric disorders |
US7649098B2 (en) * | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
TW200920355A (en) * | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2801794A1 (de) * | 1978-01-17 | 1979-07-19 | Basf Ag | Verfahren zur herstellung von thiazolderivaten und neue thiazole |
US5554620A (en) * | 1993-09-14 | 1996-09-10 | Sterling Winthrop Inc. | Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof |
SE9401965D0 (sv) * | 1994-06-07 | 1994-06-07 | Astra Ab | New compounds |
-
1994
- 1994-06-07 SE SE9401965A patent/SE9401965D0/xx unknown
-
1995
- 1995-05-18 IL IL11377395A patent/IL113773A/xx not_active IP Right Cessation
- 1995-05-22 ZA ZA954145A patent/ZA954145B/xx unknown
- 1995-05-22 HR HR9401965-0A patent/HRP950302A2/xx not_active Application Discontinuation
- 1995-05-29 CA CA002190128A patent/CA2190128A1/en not_active Abandoned
- 1995-05-29 JP JP8500744A patent/JPH10503172A/ja active Pending
- 1995-05-29 WO PCT/SE1995/000604 patent/WO1995033747A1/en not_active Application Discontinuation
- 1995-05-29 AU AU26859/95A patent/AU691303B2/en not_active Ceased
- 1995-05-29 NZ NZ287973A patent/NZ287973A/en unknown
- 1995-05-29 BR BR9507923A patent/BR9507923A/pt not_active Application Discontinuation
- 1995-05-29 EE EE9600197A patent/EE9600197A/xx unknown
- 1995-05-29 CN CN95193504A patent/CN1051546C/zh not_active Expired - Fee Related
- 1995-05-29 EP EP95922031A patent/EP0765325A1/en not_active Ceased
- 1995-05-29 HU HU9603386A patent/HUT76050A/hu unknown
- 1995-05-29 PL PL95318470A patent/PL318470A1/xx unknown
- 1995-05-29 RU RU97100178/04A patent/RU2155763C2/ru active
- 1995-05-29 SK SK1556-96A patent/SK155696A3/sk unknown
- 1995-05-29 US US08/448,411 patent/US5843971A/en not_active Expired - Fee Related
- 1995-05-29 CZ CZ963577A patent/CZ357796A3/cs unknown
- 1995-06-01 MA MA23913A patent/MA23574A1/fr unknown
- 1995-06-06 TN TNTNSN95065A patent/TNSN95065A1/fr unknown
- 1995-06-07 YU YU38695A patent/YU38695A/sh unknown
- 1995-06-07 US US08/485,719 patent/US5665747A/en not_active Expired - Fee Related
- 1995-07-03 DZ DZ950069A patent/DZ1895A1/fr active
-
1996
- 1996-11-12 IS IS4383A patent/IS4383A/is unknown
- 1996-12-04 NO NO965182A patent/NO307421B1/no not_active IP Right Cessation
- 1996-12-05 FI FI964879A patent/FI964879A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
SE9401965D0 (sv) | 1994-06-07 |
NO965182L (no) | 1996-12-04 |
YU38695A (sh) | 1998-12-23 |
EE9600197A (et) | 1997-06-16 |
AU691303B2 (en) | 1998-05-14 |
BR9507923A (pt) | 1997-09-23 |
US5843971A (en) | 1998-12-01 |
EP0765325A1 (en) | 1997-04-02 |
FI964879A0 (fi) | 1996-12-05 |
CA2190128A1 (en) | 1995-12-14 |
NO965182D0 (no) | 1996-12-04 |
HU9603386D0 (en) | 1997-01-28 |
DZ1895A1 (fr) | 2002-02-17 |
HRP950302A2 (en) | 1997-08-31 |
PL318470A1 (en) | 1997-06-23 |
CN1150426A (zh) | 1997-05-21 |
HUT76050A (en) | 1997-06-30 |
SK155696A3 (en) | 1997-05-07 |
JPH10503172A (ja) | 1998-03-24 |
FI964879A (fi) | 1996-12-05 |
MA23574A1 (fr) | 1995-12-31 |
CZ357796A3 (en) | 1997-06-11 |
CN1051546C (zh) | 2000-04-19 |
IS4383A (is) | 1996-11-12 |
NZ287973A (en) | 1998-04-27 |
IL113773A0 (en) | 1995-08-31 |
AU2685995A (en) | 1996-01-04 |
TNSN95065A1 (fr) | 1996-02-06 |
RU2155763C2 (ru) | 2000-09-10 |
ZA954145B (en) | 1995-12-07 |
WO1995033747A1 (en) | 1995-12-14 |
US5665747A (en) | 1997-09-09 |
IL113773A (en) | 2000-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO308660B1 (no) | Nye 2,3-diketopiperazin-derivater eller deres salter, anvendelse derav og farmasøytisk preparat inneholdende slike | |
NO944700D0 (no) | Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene | |
NO306401B1 (no) | Oksazolidindionderivater, farmasöytisk preparat inneholdende slike derivater, og deres anvendelse | |
NO973608D0 (no) | Nye farnesyl-transferaseinhibitorer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
NO973923L (no) | Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
NO973222D0 (no) | Nye farnesyl-transferase-inhibitorer, deres fremstilling samt farmasöytiske preparater inneholdende inhibitorene | |
NO982802L (no) | Nye 5-amino-3-cyano-4-etylsulfinyl-1-fenyl-pyrazol-forbindelser og deres anvendelse som pesticider | |
NO952677D0 (no) | Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater | |
NO951283D0 (no) | Nye taxanderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene | |
DK0562583T3 (da) | Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
NO942910L (no) | Nye baccatin-III- og 10-desacetyl-baccatin-III-derivater, deres fremstillinger, samt farmasöytiske preparater inneholdende derivatene | |
NO307510B1 (no) | Bicykliske aromatiske forbindelser, deres anvendelse og farmasøytiske og kosmetiske preparater derav | |
NO942303D0 (no) | Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav | |
NO305955B1 (no) | Nye (1-heteroazolyl-1-heterocyklyl)alkanderivater, mellomprodukter for deres fremstilling, farmasoeytisk preparat inneholdende slike derivater, og deres anvendelse til fremstilling av neurobeskyttende midler | |
NO306060B1 (no) | Substituerte kanelsyreguanidider, deres anvendelse samt medikamenter inneholdende guanididene | |
NO974563D0 (no) | Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
DK494589A (da) | Substituerede 1,3,5-triazintrioner og deres anvendelse samt mellemprodukter til deres fremstilling | |
NO307421B1 (no) | Nye 1,1-bis(heteroazolyl)alkanderivater, farmasøytisk preparat inneholdende slike derivater, deres anvendelse, samt mellomprodukter | |
NO960029L (no) | Nye (1-fenyl-1-heterocyklyl)alkanderivater og deres anvendelse som neurobeskyttelsesmidler | |
NO305953B1 (no) | Nye (1-fenyl-1-hydrocyclyl)metanol- og (1-fenyl-heterocyclyl)metylaminderivater, farmasoeytisk preparat inneholdende slike derivater og anvendelse derav | |
FI865347A0 (fi) | Gonadoliberinderivat som innehaoller en aromatisk aminokarbozylsyra i position 6, farmaceutiska och veterinaera preparat innehaollande dessa och foerfarande foer framstaellning daerav. | |
NO902473L (no) | Nye pyridobenzoindolderivater, deres fremstilling og preparater inneholdende forbindelsene. | |
NO307512B1 (no) | Nye indolforbindelser, farmasøytisk preparat inneholdende slike forbindelser, og deres anvendelse | |
NO306672B1 (no) | N,N-dietyl-8,8-dipropyl-2-azaspiro[4,5]decan-2-propanamindimaleat, farmasöytisk blanding omfattende forbindelsen samt anvendelse derav | |
NO943236D0 (no) | Nye 1,2-ditiol-3-tionderivater og farmasöytisk preparat inneholdende disse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2002 |